113 related articles for article (PubMed ID: 37236831)
21. An international comparison of treatment and short-term overall survival for older patients with pancreatic cancer.
de Leede N; Bastiaannet E; van der Geest L; Egan K; van de Velde C; Balducci L; Bonsing B; Extermann M
J Geriatr Oncol; 2019 Jul; 10(4):584-590. PubMed ID: 30799177
[TBL] [Abstract][Full Text] [Related]
22. Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID).
Brugel M; Letrillart L; Evrard C; Thierry A; Tougeron D; El Amrani M; Piessen G; Truant S; Turpin A; d'Engremont C; Roth G; Hautefeuille V; Regimbeau JM; Williet N; Schwarz L; Di Fiore F; Borg C; Doussot A; Lambert A; Moulin V; Trelohan H; Bolliet M; Topolscki A; Ayav A; Lopez A; Botsen D; Piardi T; Carlier C; Bouché O
Eur J Cancer; 2022 May; 166():8-20. PubMed ID: 35259629
[TBL] [Abstract][Full Text] [Related]
23. Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study.
Thomassen I; Lemmens VE; Nienhuijs SW; Luyer MD; Klaver YL; de Hingh IH
Pancreas; 2013 Jan; 42(1):72-5. PubMed ID: 22850624
[TBL] [Abstract][Full Text] [Related]
24. The incidence and outcomes of pancreatectomy in patients with metastatic pancreatic adenocarcinoma.
McKenzie S; Mailey B; Artinyan A; Kim J; Ellenhorn JD
JOP; 2010 Jul; 11(4):341-7. PubMed ID: 20601808
[TBL] [Abstract][Full Text] [Related]
25. Nationwide improvement of only short-term survival after resection for pancreatic cancer in the Netherlands.
Nienhuijs SW; van den Akker SA; de Vries E; de Hingh IH; Visser O; Lemmens VE
Pancreas; 2012 Oct; 41(7):1063-6. PubMed ID: 22617713
[TBL] [Abstract][Full Text] [Related]
26. The incidence and survival rate of population-based pancreatic cancer patients: Shanghai Cancer Registry 2004-2009.
Luo J; Xiao L; Wu C; Zheng Y; Zhao N
PLoS One; 2013; 8(10):e76052. PubMed ID: 24130758
[TBL] [Abstract][Full Text] [Related]
27. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
[TBL] [Abstract][Full Text] [Related]
28. Benefit of postoperative adjuvant therapy for pancreatic cancer: A population-based analysis.
Vanderveen KA; Chen SL; Yin D; Cress RD; Bold RJ
Cancer; 2009 Jun; 115(11):2420-9. PubMed ID: 19301434
[TBL] [Abstract][Full Text] [Related]
29. Impact of the SARS-CoV-2 pandemic on pancreatic cancer: diagnosis and short-term survival.
Tejedor-Tejada J; Gómez-Díez C; Robles Gaitero S; Villar Caamaño A; Hermida Pérez B; Olmos JM; Álvarez Álvarez A; Tojo González R
Rev Esp Enferm Dig; 2022 Aug; 114(8):509-510. PubMed ID: 35297265
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic Adenocarcinoma in the Finistère Area, France, Between 2002 and 2011 (1002 Cases): Population Characteristics, Treatment and Survival.
Arnachellum RP; Cariou M; Nousbaum JB; Jezequel J; Le Reste JY; Robaszkiewicz M
Pancreas; 2016 Aug; 45(7):953-60. PubMed ID: 26765965
[TBL] [Abstract][Full Text] [Related]
31. The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer.
Gruhl JD; Garrido-Laguna I; Francis SR; Affolter K; Tao R; Lloyd S
Cancer Med; 2020 Mar; 9(5):1703-1711. PubMed ID: 31945808
[TBL] [Abstract][Full Text] [Related]
32. A Nationwide Population-Based Study on the Survival of Patients with Pancreatic Neuroendocrine Tumors in The Netherlands.
Genc CG; Klümpen HJ; van Oijen MGH; van Eijck CHJ; Nieveen van Dijkum EJM
World J Surg; 2018 Feb; 42(2):490-497. PubMed ID: 29018912
[TBL] [Abstract][Full Text] [Related]
33. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
[TBL] [Abstract][Full Text] [Related]
34. Treatment Access and Survival Amongst British Asians with Pancreatic Cancer.
Isherwood J; Bilku D; Metcalfe MS; Dennison AR; Garcea G
World J Surg; 2017 Feb; 41(2):546-551. PubMed ID: 27600708
[TBL] [Abstract][Full Text] [Related]
35. Underestimation of pancreatic cancer in the national cancer registry - Reconsidering the incidence and survival rates.
Fest J; Ruiter R; van Rooij FJ; van der Geest LG; Lemmens VE; Ikram MA; Coebergh JW; Stricker BH; van Eijck CH
Eur J Cancer; 2017 Feb; 72():186-191. PubMed ID: 28033529
[TBL] [Abstract][Full Text] [Related]
36. Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands.
Zijlstra M; van der Geest LGM; van Laarhoven HWM; Lemmens VEPP; van de Poll-Franse LV; Raijmakers NJH
Acta Oncol; 2018 Sep; 57(9):1185-1191. PubMed ID: 29741436
[TBL] [Abstract][Full Text] [Related]
37. [Incidence, Treatment and Survival in Pancreatic Cancer- Data of the Nationwide Oncological Quality Conference from a Surgical Perspective].
Deichmann S; Dworschak O; Kulemann B; Höppner J; Bolm L; Klinkhammer-Schalke M; Zeissig SR; Kleihus van Tol K; Braun R; Lapshyn H; Keck T; Wellner UF; Honselmann KC
Zentralbl Chir; 2022 Apr; 147(2):147-154. PubMed ID: 35378553
[TBL] [Abstract][Full Text] [Related]
38. Quality of Life in Patients with Pancreatic Cancer before and during the COVID-19 Pandemic.
Alexander A; Fung S; Eichler M; Lehwald-Tywuschik N; Uthayakumar V; Safi SA; Vay C; Ashmawy H; Kalmuk S; Rehders A; Vaghiri S; Knoefel WT
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329416
[TBL] [Abstract][Full Text] [Related]
39. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
[TBL] [Abstract][Full Text] [Related]
40. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
